These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10301037)

  • 1. Marketing Medicaid drugs: an analysis of cost factors.
    Simmons SA; Payne BC; Smith MC
    J Health Care Mark; 1986 Sep; 6(3):29-36. PubMed ID: 10301037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marketing to public-aid recipients: an examination of pharmacy profitability.
    Tootelian DH; Gaedeke RM; Gordon CL
    J Health Care Mark; 1984; 4(4):17-21. PubMed ID: 10311025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cluster analysis of state Medicaid prescription drug benefit programs based on potential determinants of per capita drug expenditure.
    Roy S; Madhavan SS
    Res Social Adm Pharm; 2009 Mar; 5(1):51-62. PubMed ID: 19285289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and risk factors associated with high-cost Medicaid recipients.
    Guo JJ; Ludke RL; Heaton PC; Moomaw CJ; Ho M; Cluxton RJ
    Manag Care Interface; 2004 Oct; 17(10):20-7. PubMed ID: 15535074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Department of Health and Human Services. Medicaid pharmacy management strategy--2003-2005.
    Odom CH; Wade T
    N C Med J; 2003; 64(6):278-9. PubMed ID: 14983616
    [No Abstract]   [Full Text] [Related]  

  • 11. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 12. Medication restrictions: feeling the side effects.
    Fitzpatrick C
    Behav Healthc Tomorrow; 2001 Oct; 10(5):14-7, 39-40. PubMed ID: 11594068
    [No Abstract]   [Full Text] [Related]  

  • 13. How does Cash and Counseling affect costs?
    Dale SB; Brown RS
    Health Serv Res; 2007 Feb; 42(1 Pt 2):488-509. PubMed ID: 17244294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare and Medicaid programs; limits on payments for drugs--HCFA. Final rule.
    Fed Regist; 1987 Jul; 52(147):28648-58. PubMed ID: 10301766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of Medicaid annuities.
    Levy RA; Nyman JA; Gabay M; Riley W; Feldman R
    Health Aff (Millwood); 2006; 25(2):444-51. PubMed ID: 16522585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and utilization analysis of a pediatric emergency department diversion project.
    Wang C; Villar ME; Mulligan DA; Hansen T
    Pediatrics; 2005 Nov; 116(5):1075-9. PubMed ID: 16263992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promises unfulfilled: implementation of expanded coverage for the elderly poor.
    Lamphere JA; Rosenbach ML
    Health Serv Res; 2000 Apr; 35(1 Pt 2):207-17. PubMed ID: 10778810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
    Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.